Stage II Gastric Cancer
3 clinical trials · Condition
◉ Watch Stage II Gastric Cancer
| Record | Firm | Date |
|---|---|---|
| Oxaliplatin, Fluorouracil, Erlotinib Hydrochloride, and Radiation Therapy Before Surgery and Erlotinib Hydrochloride After Surgery in Treating Patients With Locally Advanced Cancer of the Esophagus or Gastroesophageal Junction (NCT01561014) | Wake Forest University Health Sciences | 2007-04-01 |
| EF5 and Motexafin Lutetium in Detecting Tumor Cells in Patients With Abdominal or Non-Small Cell Lung Cancer (NCT00087191) | National Cancer Institute (NCI) | 2004-05-01 |
| Irinotecan and Cisplatin in Treating Patients Who Are Undergoing Surgery For Locally Advanced Cancer of the Stomach or Gastroesophageal Junction (NCT00062374) | National Cancer Institute (NCI) | 2003-06-01 |
Track Stage II Gastric Cancer automatically
Every clearance here is in the API, with alerts when new ones post.